Organon (OGN) Accounts Payables (2020 - 2026)

Organon has reported Accounts Payables for 7 years, with the latest figure at $1.1 billion in Q2 2026.

• On a quarterly basis, Accounts Payables fell 1.5% year-over-year to $1.1 billion in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 1.5% decrease from a year earlier, with the FY2025 full-year figure at $952.0 million, down 17.43% from the prior year.
• Accounts Payables was $1.1 billion for Q2 2026 at Organon, up from $983.0 million in the prior quarter.
• The five-year high for Accounts Payables was $1.3 billion in Q4 2023, with the low at $952.0 million in Q4 2025.
• Average Accounts Payables over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2023.
• The largest YoY upside for Accounts Payables was 309.47% in 2022 against a maximum downside of 38.55% in 2022.
• Over 5 years, Accounts Payables stood at $1.1 billion in 2022, then grew by 16.08% to $1.3 billion in 2023, then decreased by 12.25% to $1.2 billion in 2024, then retreated by 17.43% to $952.0 million in 2025, then advanced by 10.4% to $1.1 billion in 2026.
• The last three Accounts Payables figures came in at $1.1 billion (Q2 2026), $983.0 million (Q1 2026), and $952.0 million (Q4 2025), per Business Quant data.